Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20200825048515N33Phase 3Completed
Phase 3, randomised, double-blind trial comparing Atropine with Placebo (2 arms). Primary endpoints: Delirium, Pain and 3 more. Started May 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20200825048515N33.